Coloplast A/S (COLOb.CO)

COLOb.CO on Copenhagen Stock Exchange

506.00DKK
5 Feb 2016
Change (% chg)

kr.-10.50 (-2.03%)
Prev Close
kr.516.50
Open
kr.515.50
Day's High
kr.516.00
Day's Low
kr.505.00
Volume
437,085
Avg. Vol
356,746
52-wk High
kr.586.50
52-wk Low
kr.413.10

COLOb.CO

Chart for COLOb.CO

About

Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for... (more)

Overall

Beta: 0.67
Market Cap(Mil.): kr.102,212.00
Shares Outstanding(Mil.): 202.00
Dividend: 8.00
Yield (%): 2.47

Financials

  COLOb.CO Industry Sector
P/E (TTM): 116.13 88.34 38.72
EPS (TTM): 4.36 -- --
ROI: 16.68 11.16 14.47
ROE: 19.68 13.57 15.40
Search Stocks

CORRECTED-BRIEF- Coloplast Q1 EBIT misses expectations

* Q1 EBIT 1.19 billion Danish crowns ($174 million) versus 1.21 billion seen in Reuters poll

02 Feb 2016

RPT-BRIEF-Coloplast Q1 EBIT misses expectations

* Q1 EBIT 1.19 billion Danish crowns ($174 million) versus 1.21 billion seen in Reuters poll

02 Feb 2016

BRIEF-Coloplast Q1 EBIT misses expectations

* Q1 EBIT 1.19 billion Danish crowns ($174 million) versus 1.21 billion seen in Reuters poll

02 Feb 2016

BRIEF-Coloplast cancels 4 million shares

* Says reduces share capital as informed in an earlier stock exchange announcement

08 Jan 2016

BRIEF-Coloplast says settles with US Department of Justice

* Says under terms of agreement, Coloplast will pay $3.1 million, and legal costs

23 Dec 2015

BRIEF-Coloplast dividend approved by the general meeting

* Says distribution of ordinary dividend of 8.00 Danish crowns ($1.18) per share was approved by the general meeting.

09 Dec 2015

UPDATE 1-Coloplast's full-year result drops 62 pct on lawsuits costs

COPENHAGEN, Nov 3 Danish healthcare products maker Coloplast saw fourth-quarter operating profit before taxes swing into a loss and its full-year results fall 62 percent after it set aside 3 billion Danish crowns ($445 million) for U.S. lawsuits.

03 Nov 2015

Coloplast posts better Q4 results than expected

COPENHAGEN, Nov 3 Danish healthcare products maker Coloplast reported a fourth-quarter operating loss better than expected on Tuesday, following several profit warnings throughout its financial year due to provisions it set aside for U.S. lawsuits.

03 Nov 2015

BRIEF-Coloplast sees 7-8 pct organic revenue growth in 2015-2016

* Says for 2015-2016, expects organic revenue growth of 7-8 percent at constant exchange rates and 8-9 percent in DKK

03 Nov 2015

BRIEF-Coloplast launch urinary video probe in collaboration with Ambu

* Says the videoscope will be available in market from December 2015

05 Oct 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Directors Deals Ltd.
$12.00
Provider : GlobalData
$300.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks